Journals / Genel Tıp Dergisi / 2012 / Cilt: 22 - Sayı: 4

Current status of reirradiation for head and neck tumors

Baş-boyun tümörlerinde reirradyasyondaki güncel gelişmeler

Pages
141–150
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However for the patients who are not appropriate for surgery or for those with postoperative poor prognostic factors, reirradiation is an alternative treatment option

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Despite advances in the treatment of head and neck cancer, 15-50%of patients will develop recurrent disease.
📊
Key Findings & Data:The incidence of developing a second primary tumor is approximately 14-20%during lifeti- me.
💡
Conclusion & Impact:However for the patients who are not appropriate for surgery or for those with postoperative poor prognostic factors, reirradiation is an alternative treatment option
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Despite advances in the treatment of head and neck cancer, 15-50%of patients will develop recurrent disease. Survivors also are at risk to develop second primary tumors. The incidence of developing a second primary tumor is approximately 14-20%during lifeti- me. Therapeutic options are limited for patients who present with locally advanced disease or a second primary disease within the previously irradiated region. Salvage surgery is the preferred option for those with limited-volume disease. However for the patients who are not appropriate for surgery or for those with postoperative poor prognostic factors, reirradiation is an alternative treatment option

Özet

Baş-boyun kanserlerinin tedavisindeki ilerlemelere rağmen %15-50 hastada nüks hastalık gelişmektedir. Tedavi sonrasında takipler- de bu hastalarda ikinci primer hastalık geliştirme riski de yüksektir. Bu risk hayat boyu %14-20'dir. Daha önce radyoterapi uygulan- mış bölgede lokal nüksü gelişen ya da radyoterapi alanı içerisinde ikinci primer tümörü gelişen hastalarda tedavi seçenekleri kısıtlıdır. Sınırlı hacimde tümörü olan hastalarda tercih edilen tedavi şekli kurtarma cerrahisidir. Ancak kurtarma cerrahisi için uygun olmayan ya da cerrahi sonu kötü prognostik faktörleri bulunan hastalarda reirradyasyon alternatif bir tedavi seçeneğidir

🔖

Cite This Article

YAVAŞ, G., YAVAŞ, Ç. (2012). Current status of reirradiation for head and neck tumors. Genel Tıp Dergisi, Cilt: 22 - Sayı: 4, 141–150. https://ajindex.com/articles/205968

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bourhis J, Le Maitre A, Baujat B, et al. Individual patients’ data meta-analyses in head and neck cancer. Curr Opin Oncol 2007;19:188
  2. Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004;15:1179
  3. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945
  4. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937
  5. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091
  6. Hall SF, Groome PA, Irish J, O’Sullivan B. The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 2008;118:1362
  7. Haughey BH, Gates GA, Arfken CL, Harvey J. Metaanalysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992;10:105–112
  8. Nishijima W, Takooda S, Tokita N, Takayama S, Sakura M. Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg 1993;119:65-8
  9. Spencer SA, Harris J, Wheeler RH, et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 2008;30:281–8
  10. Sciubba JJ. End of life considerations in the head and neck cancer patient. Oral Oncol 2009;45:431-4
  11. Kao J, Garofalo MC, Milano MT, et al. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 2003;29:21
  12. Chmura SJ, Milano MT, Haraf DJ. Reirradiation of recurrent head and neck cancers with curative intent. Semin Oncol 2004;31:816
  13. McDonald MW, Lawson J, Garg MK, et al. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys 2011;80:1292
  14. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carc